Aarti Drugs bonus shares: history and record dates
NSE: AARTIDRUGSBSE: 524348Pharmaceuticals & BiotechnologySmall Cap
Aarti Drugs Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 1993 on BSE, Sep 2003 on NSE
Last close ₹435.20down ₹13.80 (3.07%)BSE ₹435.70
Share price at the NSE close on 30 Oct 2026. Previous close ₹449.00.
30 Oct: open ₹444.00, high ₹449.00, low ₹432.50
52-week range of traded prices to 30 Oct 2026
₹318.95Low, 30 Mar 2026₹534.00High, 10 Nov 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3,972 Cr930th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.78
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.56
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.46%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.37
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,91,56330.3% delivered
Aarti Drugs' bonus issues since Jan 2007, the latest gone ex on 30 Sep 2020, with each one's ratio, ex-date and record date and what one share held before them became.
What one share became
Neither changes what a holding is worth on the day.Aarti Drugs dividend history
One share held before 24 Mar 20158 shares todayShares today for one share held before. One share multiplied by the share factor of this bonus or split and of every one after it: a 1:1 bonus doubles the count, and a split of a ₹10 share into ₹2 shares multiplies it by five. Shares today for one share held before in the glossary
- Bonus issues
- 2
Bonus issues: ratio, ex-date and record date
A bonus issue gives holders free extra shares in a fixed ratio. On record from 2007.All upcoming bonus issues
Shares today for one held before the ex-date, after every event since
- 30 Sep 2020 · ex-date3 for 1 bonusRecord date 1 Oct 20204 shares todayfor 1 held before 30 Sep 2020
- 24 Mar 2015 · ex-date1 for 1 bonusRecord date 25 Mar 20158 shares todayfor 1 held before 24 Mar 2015
Buybacks
Every one on record, latest first.
- Buyback · 5 Sep 2024 · record date 5 Sep 2024Tender offer to holders on the record date at ₹900 a share for 6,65,000 shares, open 11 Sep 2024 to 19 Sep 2024. Holders tendered 99.05 times the shares on offer.
- Buyback · 4 Aug 2023 · record date 4 Aug 2023Tender offer to holders on the record date at ₹900 a share for 6,65,000 shares, open 9 Aug 2023 to 17 Aug 2023. Holders tendered 103.65 times the shares on offer.
- Buyback · 30 Mar 2021 · record date 1 Apr 2021Tender offer to holders on the record date at ₹1,000 a share, open 27 Apr 2021 to 10 May 2021.
- Buyback · 28 Mar 2019 · record date 29 Mar 2019Tender offer to holders on the record date at ₹900 a share, open 3 May 2019 to 16 May 2019.
- Buyback · 18 Jan 2018 · record date 19 Jan 2018Tender offer to holders on the record date at ₹875 a share, open 14 Feb 2018 to 28 Feb 2018.
- Buyback · 1 Nov 2016 · record date 2 Nov 2016Tender offer to holders on the record date at ₹750 a share, open 2 Dec 2016 to 16 Dec 2016.